Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma.

Current treatment options in oncology - 1 Feb 2024

Gritsch David, Santagata Sandro, Brastianos Priscilla K

Abstract excerpt

OPINION STATEMENT: The integration of targeted therapy into the multimodal management of craniopharyngiomas represents a significant advancement in the field of neuro-oncology. Historically, the management of these tumors has been challenging due to their proximity to vital brain structures, necessitating a delicate balance between tumor control and the preservation of neurological function. Traditional treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Craniopharyngioma
Share to Mitogen-Activated Protein Kinase Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Pituitary Neoplasms

Share to Proto-Oncogene Proteins B-raf

Share to Quality of Life

Source

Open in PubMed Open full text

Identifiers

PMID: 38300480
DOI: 10.1007/s11864-023-01156-2
PMCID: PMC11203386

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma.PMID 38300480Read ↗

Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy.Semantic proximity Read ↗

The Medical Therapy of Craniopharyngiomas: The Way AheadSemantic proximity Read ↗

Practical application of precision oncology in adult onset craniopharyngiomas.Semantic proximity Read ↗

First evidence of anti-VEGF efficacy in an adult case of adamantinomatous craniopharyngioma: Case report and illustrative review.Semantic proximity Read ↗

Targeted therapies in the medical management of craniopharyngioma.Semantic proximity Read ↗

[Molecularly Targeted Therapy for Craniopharyngioma].Semantic proximity Read ↗

[Craniopharyngiomas: The Dawn of a New Era with the Elucidation of Driver Genes].Semantic proximity Read ↗

Contemporary Biological Insights and Clinical Management of Craniopharyngioma.Semantic proximity Read ↗

Study protocol for preoperative classification using integrated screening and short-course neoadjuvant BRAF/MEK inhibition in newly diagnosed papillary craniopharyngioma (the PRECISE-PCP study): a prospective single-arm studySemantic proximity Read ↗

Current treatment options for meningioma.Semantic proximity Read ↗

BRAF plus MEK inhibition effective in papillary craniopharyngioma.Semantic proximity Read ↗

Molecular oncogenesis of craniopharyngioma: current and future strategies for the development of targeted therapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.